Hikma Pharmaceuticals PLC hit a new 52-week high, surpassing its previous peak of £23.14, which the company achieved on ...

PLC (LSE: HIK), a global pharmaceutical company, is set to announce its financial results for the year ending December 31, 2024, on Wednesday, February 26, 2025. The company will make a recording of ...

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

The introduction of the Shield™ test for colorectal cancer screening marks a transformative step in advancing precision and ...

A new wave of hope is sweeping across Europe and MENA for millions of cancer patients seeking affordable and effective treatment options. The rise of generic oncology drugs is offering a much-needed ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.75% to £21.30 Friday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.73 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Software spending in the Middle East and North Africa (Mena) is set to soar, with projections estimating it will reach $19.98 billion by 2025. This surge is primarily fuelled by the growing demand ...